Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 9:20 p.m.

    📋 Form 144 Filing: Heyman Richard A.

    Company: Enliven Therapeutics, Inc.

    Filing Date: 2026-01-08

    Relationship: Director

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 12,300
    • Price per Share: $15.47
    • Total Value: $190,281.00
    • Planned Sale Date: 2026-01-08
    • Broker: Jefferies LLC
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-39247
    • Issuer Contact Phone: 720-647-8519
    • Issuer Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
    • Broker Address: 520 Madison Ave, 4th Fl, New York, NY, 10022
    • Shares Outstanding: 59000000.0
    • Number of Securities to be Sold: 1
    • Signature: Richard Heyman
    • Plan Adoption Dates: 2024-11-15

Search

News categories